Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,615.00
+70.00 (1.97%)
At close: Nov 26, 2025
Market Cap100.05B
Revenue (ttm)108.14B
Net Income (ttm)1.41B
Shares Out27.68M
EPS (ttm)60.34
PE Ratio59.91
Forward PEn/a
Dividend30.00 (0.85%)
Ex-Dividend DateMar 4, 2025
Volume58,722
Average Volume129,681
Open3,520.00
Previous Close3,545.00
Day's Range3,520.00 - 3,655.00
52-Week Range2,995.00 - 4,890.00
Beta0.37
RSI43.89
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.